MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas

Improved biomarkers are needed for vestibular schwannoma (VS), the most common tumor of the cerebellopontine angle, as existing clinical biomarkers have poor predictive value. Factors such as tumor size or growth rate do not shed light on the pathophysiology of associated sensorineural hearing loss...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yin, Hyakusoku, Hiroshi, Sagers, Jessica E., Landegger, Lukas D., Welling, D. Bradley, Stankovic, Konstantina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424165/
https://www.ncbi.nlm.nih.gov/pubmed/32848608
http://dx.doi.org/10.3389/fncel.2020.00191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424165/
https://www.ncbi.nlm.nih.gov/pubmed/32848608
http://dx.doi.org/10.3389/fncel.2020.00191

Ejemplares similares